Serial 98241061
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98241061
- Registration number
- 7666879
- Mark type
- Design / logo
- Filed
- 26 Oct 2023
- Published for opposition
- 10 Dec 2024
- Registered
- 28 Jan 2025
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; Biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes
- Class 042 — Scientific and technological services: Medical, scientific and industrial research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development services, namely configuration and customization of computer databases containing information regarding medical, pharmaceutical and biopharmaceutical information; Pharmaceutical drug development services
- Class 044 — Medical, beauty and agricultural services: Medical services; providing medical and pharmaceutical advice; gene bank services
Owner
- Galapagos NV, Mechelen, BE
- Galapagos NV, Mechelen, BE
- Galapagos NV, Mechelen, BE
Prosecution history
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2024 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 06 Aug 2024 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 23 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Jun 2024 — NON-FINAL ACTION E-MAILED
- 13 Jun 2024 — NON-FINAL ACTION WRITTEN